Maintaining actively growing rare patient-derived cells is challenging, but the tumor organoid RMS cells RMS102 (PAX3-FOXO1), RMS127 (PAX3-FOXO1) and RMS335 (PAX7-FOXO1) could be successfully passaged in vitro using previously published cultivation conditions (27). This evidence concerns the gene FOXO1 and neoplasm.